Neurodegeneration: Etiologies and New Therapies

Neurodegeneration: Etiologies and New Therapies 2016

1Department of Neurology, Singapore General Hospital, National Neuroscience Institute and Duke NUS Graduate Medical School, Singapore 169857 2Department of Pediatric Surgery, University of Texas Health Sciences Center at Houston, Houston, TX 77030, USA 3Department of Neurology, Division of Neuromuscular Disorders and Department of PM&R and Department of Neuroscience, The Ohio State University W...

P142: Inflammation or Neurodegeneration: Which one has Remarkable Role in Multiple Sclerosis?

Multiple Sclerosis (MS) is a complex disease resulting from the occurrence of intermingled episodes of neuroinflammation and degeneration. However, this concept has recently challenged by several observations suggesting that in this disease neurodegeneration might occur independently of inflammation. The evidence that active neurodegeneration in MS is invariably associated with inflammation is p...

Modeling and imaging cardiac sympathetic neurodegeneration in Parkinson's disease.

Parkinson's disease (PD) is currently recognized as a multisystem disorder affecting several components of the central and peripheral nervous system. This new understanding of PD helps explain the complexity of the patients' symptoms while challenges researchers to identify new diagnostic and therapeutic strategies. Cardiac neurodegeneration and dysautonomia affect PD patients and are associate...

Neurodegeneration. Huntington's research points to possible new therapies.

Management of fatigue in the cancer patient.

Fatigue is one of the most common symptoms experienced by patients with cancer and other progressive diseases. Although reported to be a major obstacle to maintaining normal daily activities and quality of life, remarkably few studies of this syndrome have been conducted. This trend is slowly changing with the recognition of fatigue as a diagnosis by the International Classification of Diseases...